The disclosure provides methods of preventing or treating metabolic syndrome in a subject by administering an effective amount of an inhibitor of laminin α4 expression, laminin α4 activity, or both.
Details
Title
MODULATION OF LAMININ ALPHA-4 IN THE PREVENTION, TREATMENT, AND MANAGEMENT OF METABOLIC SYNDROMES
Inventors
Vaicik, Marcella K. : Illinois Institute of Technology Cohen, Ronald N. : University of Chicago Brey, Eric M. : Illinois Institute of Technology Tryggvason, Karl : Karolinska Institutet Kortesmaa, Jill Thyboll : Karolinska Institutet
Applicants
University of Chicago Illinois Institute of Technology
Content Type
Patent
Assignees
University of Chicago Illinois Institute of Technology
